On the Aggregation of Apolipoprotein A-I

被引:5
|
作者
Frankel, Rebecca [1 ,2 ]
Sparr, Emma [2 ]
Linse, Sara [1 ]
机构
[1] Lund Univ, Biochem & Struct Biol, POB 124, SE-22100 Lund, Sweden
[2] Lund Univ, Div Phys Chem, POB 124, SE-22100 Lund, Sweden
基金
瑞典研究理事会; 欧洲研究理事会;
关键词
apolipoprotein A-I; aggregation; condensates; plaques; HIGH-DENSITY-LIPOPROTEINS; CIRCULAR-DICHROISM; ALZHEIMERS-DISEASE; BASIC MECHANISMS; HDL; MYELOPEROXIDASE; NOMENCLATURE;
D O I
10.3390/ijms23158780
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In vivo, apolipoprotein A-I (ApoA-I) is commonly found together with lipids in so-called lipoprotein particles. The protein has also been associated with several diseases-such as atherosclerosis and amyloidosis-where insoluble aggregates containing ApoA-I are deposited in various organs or arteries. The deposited ApoA-I has been found in the form of amyloid fibrils, suggesting that amyloid formation may be involved in the development of these diseases. In the present study we investigated ApoA-I aggregation into amyloid fibrils and other aggregate morphologies. We studied the aggregation of wildtype ApoA-I as well as a disease-associated mutant, ApoA-I K107 Delta, under different solution conditions. The aggregation was followed using thioflavin T fluorescence intensity. For selected samples the aggregates formed were characterized in terms of size, secondary structure content, and morphology using circular dichroism spectroscopy, dynamic light scattering, atomic force microscopy and cryo transmission electron microscopy. We find that ApoA-I may form globular protein-only condensates, in which the alpha-helical conformation of the protein is retained. The protein in its unmodified form appears resistant to amyloid formation; however, the conversion into amyloid fibrils rich in beta-sheet is facilitated by oxidation or mutation. In particular, the K107 Delta mutant shows higher amyloid formation propensity, and the end state appears to be a co-existence of beta-sheet rich amyloid fibrils and alpha-helix-rich condensates.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Apolipoprotein A-I Mimetic Peptides
    Van Lenten, Brian J.
    Wagner, Alan C.
    Anantharamaiah, G. M.
    Navab, Mohamad
    Reddy, Srinivasa T.
    Buga, Georgette M.
    Fogelman, Alan M.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (01) : 52 - 57
  • [22] IMMUNOLOGICAL ESTIMATION OF APOLIPOPROTEIN A-I
    AYRAULTJARRIER, M
    BOBILEWICZ, D
    PASTIER, D
    BEUCLER, I
    POLONOVSKI, J
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 1982, 40 (03) : 187 - 194
  • [23] ASPECIFICITY OF APOLIPOPROTEIN A-I ANTISERA
    COBBAERT, C
    BERTELS, I
    STAELS, B
    VERHOEVEN, G
    LISSENS, W
    [J]. JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1988, 26 (05): : 291 - 291
  • [24] Human Apolipoprotein A-I Deficiency
    Schaefer, Ernst J.
    Santos, Raul D.
    [J]. HIGH DENSITY LIPOPROTEINS, DYSLIPIDEMIA, AND CORONARY HEART DISEASE, 2010, : 55 - +
  • [25] The promise of apolipoprotein A-I mimetics
    Mendez, Armando J.
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2010, 17 (02) : 171 - 176
  • [26] PHOSPHORYLATION OF HUMAN APOLIPOPROTEIN A-I
    BEG, ZH
    STONIK, JA
    HOEG, JM
    DEMOSKY, SJ
    BREWER, HB
    [J]. CIRCULATION, 1987, 76 (04) : 117 - 117
  • [27] Apolipoprotein A-I is a molecular lariat
    Segrest, JP
    Harvey, S
    Jones, MK
    [J]. CIRCULATION, 1998, 98 (17) : 2 - 2
  • [28] HUMAN APOLIPOPROTEIN A-I DEFICIENCY
    Schaefer, E.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [29] Apolipoprotein A-I mimetic peptides
    Anantharamaiah, GM
    Navab, M
    Reddy, ST
    Hama, S
    Hough, G
    Palgunachari, MN
    Datta, G
    Garber, DW
    Fogelman, AM
    [J]. BIOPOLYMERS, 2005, 80 (04) : 498 - 498
  • [30] Aggregation of lipoprotein(a) to apolipoprotein A-I underlying HDL dysfunction as a major coronary risk factor
    Onat, Altan
    Can, Gunay
    Murat, Sani
    Cicek, Gokhan
    Ornek, Ender
    Yuksel, Husniye
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2013, 13 (06): : 543 - 551